Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.32 USD
Change Today -0.065 / -1.02%
Volume 193.7K
As of 11:53 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

accuray inc (ARAY) Snapshot

Open
$6.36
Previous Close
$6.38
Day High
$6.43
Day Low
$6.25
52 Week High
04/13/15 - $10.01
52 Week Low
05/27/15 - $5.84
Market Cap
498.4M
Average Volume 10 Days
557.7K
EPS TTM
$-0.58
Shares Outstanding
79.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ACCURAY INC (ARAY)

accuray inc (ARAY) Related Businessweek News

No Related Businessweek News Found

accuray inc (ARAY) Details

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables delivery of precise, high dose radiation while patients breathe normally. The company also offers the TomoTherapy System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. Accuray Incorporated markets its products in the United States directly, as well as through a sales agent and group purchasing organizations; and directly and through distributors in Europe, Japan and rest of Asia, South America, and internationally to hospitals and stand-alone treatment facilities. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.

1,026 Employees
Last Reported Date: 08/29/14
Founded in 1990

accuray inc (ARAY) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $637.5K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $293.0K
Chief Commercial Officer and Executive Vice P...
Total Annual Compensation: $368.1K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $330.6K
Compensation as of Fiscal Year 2014.

accuray inc (ARAY) Key Developments

Accuray and RaySearch Collaborate for Oncology Information System

Accuray Incorporated and RaySearch Laboratories AB have signed a long-term collaboration agreement to co-market and offer the RayCare oncology information system, or OIS. Under the contract, Accuray will have the opportunity to offer RayCare in several designated major radiation therapy markets, making available a fully-integrated solution with the TomoTherapy and CyberKnife System product portfolios. RaySearch and Accuray are partnering to provide the radiation oncology community with a creative approach for delivering and managing precise radiation therapy. RayCare is a next generation OIS developed from the ground up by RaySearch to support the complex logistical challenges in modern large-scale radiation therapy centers. RayCare integrates the high performance radiation therapy algorithms available in RayStation and adds advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy. The system is expected to be released in 2017.

Accuray and RaySearch Announce Long-Term Collaboration Agreement Regarding the RayCare® Oncology Information System

Accuray Incorporated and RaySearch Laboratories AB (publ) announced that they have signed a long-term collaboration agreement which will allow Accuray to co-market and offer the RayCare® oncology information system (OIS) which is currently in development at RaySearch. Under the contract, Accuray will have the opportunity to offer RayCare® in several designated major radiation therapy markets, making available a fully-integrated solution with the TomoTherapy® and CyberKnife® System product portfolios. RaySearch, known for its innovative, advanced and user-friendly treatment planning software, RayStation®, and Accuray, recognized for its innovative tumor treatments, are partnering to provide the radiation oncology community with a creative approach for delivering and managing precise radiation therapy. RayCare® is a next generation OIS developed from the ground up by RaySearch to support the complex logistical challenges in modern large-scale radiation therapy centers. RayCare® integrates the high performance radiation therapy algorithms available in RayStation® and adds advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy. The system is expected to be released in 2017.

Accuray Incorporated Reports Earnings Results for the Third Quarter of 2015; Provides Earnings Guidance for the Full Year of 2015

Accuray Incorporated reported earnings results for the third quarter of 2015. For the quarter, the company generated $98 million in total revenue, which was a growth of 5% in constant currency. Positive adjusted EBITDA was $9.9 million. The company provided earnings guidance for the full year of 2015. For the period, the company expects revenue would be between $375 million and $385 million. The company expects to generate EBITDA in the remaining fiscal quarter to achieve total EBITDA for the year of between $13 million to $16 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARAY:US $6.32 USD -0.065

ARAY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Elekta AB kr57.30 SEK 0.00
Koninklijke Philips NV €25.62 EUR +0.305
Mitsubishi Heavy Industries Ltd ¥655.10 JPY -1.10
RaySearch Laboratories AB kr120.50 SEK -2.50
Varian Medical Systems Inc $85.90 USD -0.17
View Industry Companies
 

Industry Analysis

ARAY

Industry Average

Valuation ARAY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.3x
Price/Book 6.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACCURAY INC, please visit www.accuray.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.